ArticleJournal of applied clinical medical physics2025
Evaluation and failure analysis of four commercial deep learning-based autosegmentation software for abdominal organs at risk.
Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Clinical edge-case stress testing of two Asia-developed AI auto-contouring systems using prostate radiotherapy planning CT images.Radiological physics and technology · 2026Article
- Clinical evaluation of novel deep learning-based auto-segmentation software: Utility and potential pitfalls.Journal of applied clinical medical physics · 2026Article
- Robust framework for adaptive field-of-view automatic segmentation in vaginal brachytherapy for endometrial cancer.Physics and imaging in radiation oncology · 2026Article
- Clinical validation of AI-assisted contouring in prostate radiation therapy treatment planning: Highlighting automation bias and the need for standardized quality assurance.Journal of applied clinical medical physics · 2026Article
- The impact of neck tilt on the accuracy of deep learning generated contours for CT images of the head and neck.Journal of applied clinical medical physics · 2025Article
- Can Deep Learning-Based Auto-Contouring Software Achieve Accurate Pelvic Volume Delineation in Volumetric Image-Guided Radiotherapy for Prostate Cancer? A Preliminary Multicentric Analysis.Current oncology (Toronto, Ont.) · 2025Article
- Evaluation and failure analysis of four commercial deep learning-based autosegmentation software for abdominal organs at risk.Journal of applied clinical medical physics · 2025Article
- Current status and upcoming developments for online adaptive proton therapy enabling a closed feedback loop for near real-time adaptation.Frontiers in oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
purposeDeep learning-based segmentation of organs-at-risk (OAR) is emerging to become mainstream in clinical practice because of the superior performance over atlas and model-based autocontouring methods. While several commercial deep learning-based autosegmentation solutions are now available, the implementation of these tools is still at such a primitive stage that acceptance criteria are underdeveloped due to a lack of knowledge about the systems' segmentation tendencies and failure modes. As the starting point of the iterative process of clinical implementation, this study focuses on the outlier analysis of four commercial autocontouring tools for the abdominal OARs. MATERIALS AND
methodsThe autosegmentation software, developed by Limbus AI, MIM Contour ProtégéAI, Radformation AutoContour, and Siemens syngo.via, were used to segment 111 patient cases. Geometric segmentation accuracy was quantitatively compared with clinical contours using the dice similarity coefficient (DSC) and 95% Hausdorff distance (HD95). The outliers from quantitative evaluations of each software were analyzed for the liver, stomach, and kidneys with the possible causes of outliers summarized into six categories: (1) difference in contouring style or guideline, (2) image acquisition and quality, (3) abnormal anatomy of the OAR, (4) abnormal anatomy of abutting organs/tissues, (5) external/internal devices, and (6) other causes.
resultsFor the liver segmentation, the most prominent cause of discrepancies for Limbus, which occurred in four of its six outliers, was the existence of biliary stent or internal/external biliary drain as well as the resulting pneumobilia. Siemens included the abutting organs that shared CT numbers similar to those of the liver in 5/8 outliers. 12 of 13 Radformation's liver segmentation outliers included the heart and/or stomach while MIM not only included the stomach in the presence of barium in 5/11 outliers, but also produced fragmented contours in 5/11 other cases. Only Limbus and Radformation provided stomach segmentation, and imaging with barium contrast directly caused incomplete stomach delineation in 10/12 Limbus outliers and 21/25 Radformation outliers. As for the kidneys, Radformation and Siemens consistently followed the RTOG contouring guidelines, whereas the institutional contours excluded the renal pelvis in some cases, resulting in 19/25 Radformation outliers and 18/23 Siemens outliers. By contrast, Limbus contours appeared to follow different contouring guidelines that exclude the renal pelvis. Fragmented kidney contours were found in 10/15 Limbus outliers and 25/26 MIM outliers. The ones in MIM were directly linked to the use of IV contrast in imaging, but there was not enough evidence to identify the origin of Limbus's fragmented contours.
conclusionThe causes of the segmentation outliers of the four commercial deep learning-based autocontouring solutions were summarized for each OAR. This work can help the vendors improve their autosegmentation software and also inform the users of potential modes of failure when using the tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.